BioCentury
ARTICLE | Company News

RaQualia, Eli Lilly deal

July 29, 2013 7:00 AM UTC

RaQualia said it extended the research term of a December 2010 deal with Eli Lilly to identify and develop compounds against an undisclosed ion channel target to treat pain. RaQualia will receive an u...